iSpecimen (ISPC) Return on Sales (2020 - 2026)

iSpecimen's Return on Sales history runs 7 years deep, the most recent figure standing at 0.17% for Q1 2026.

• In Q1 2026, Return on Sales fell 15.0% year-over-year to 0.17%; the TTM figure through Mar 2026 stood at 0.1% (down 9.0% YoY), while the FY2025 annual figure was 0.05%, down 3.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.17%, up from 0.55% in the prior quarter.
• The five-year high for Return on Sales was 0.01% in Q3 2024, with the low at 0.55% in Q4 2025.
• The 5-year median for Return on Sales is 0.01% (2022), against an average of 0.07%.
• The sharpest annual moves came in 2024 and 2025: Return on Sales rose 1 bps in 2024, then slumped 51 bps in 2025.
• iSpecimen's Return on Sales stood at 0.01% in 2022, then tumbled by 75 bps to 0.01% in 2023, then sank by 247 bps to 0.04% in 2024, then slumped by 1198 bps to 0.55% in 2025, then surged by 69 bps to 0.17% in 2026.
• Business Quant data shows ISPC's Return on Sales at 0.17% in Q1 2026, 0.55% in Q4 2025, and 0.27% in Q3 2025.